Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

bioMérieux NucliSENS EasyQ MRSA test receives FDA clearance

bioMérieux has received 510(k) clearance from the US Food and Drug Administration (FDA) for its NucliSENS EasyQ MRSA, an automated molecular test for Methicillin Resistant Staphylococcus aureus (MRSA).

bioMérieux said, the test which detects seven MRSA types, will support efficient batch processing of up to 46 MRSA screening tests in a compact space with a rapid turn-around time of only three hours.

NucliSENS EasyQ MRSA complements chromID MRSA, bioMérieux’s chromogenic media, which enables direct, color-specific visual observation of the bacterial colonies in patient samples.

The complete suite of bioMérieux MRSA solutions includes VITEK 2 for rapid identification and antibiotic susceptibility testing, Etest for extended dilution MICs (minimum inhibitory concentration) and DiversiLab for strain typing.